MLICM
VYGR icon

Metropolitan Life Insurance Company (MetLife)’s Voyager Therapeutics VYGR Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-1,743
Closed -$16.2K – 2075
2024
Q1 		$16.2K Hold
1,743
– – ﹤0.01% 1957
2023
Q4 		$14.7K Hold
1,743
– – ﹤0.01% 2044
2023
Q3 		$13.5K Hold
1,743
– – ﹤0.01% 2079
2023
Q2 		$20K Buy
+1,743
New +$18K ﹤0.01% 1932
2020
Q4 		– Sell
-9,048
Closed -$96.5K – 2574
2020
Q3 		$96.5K Hold
9,048
– – ﹤0.01% 2239
2020
Q2 		$114K Hold
9,048
– – ﹤0.01% 2176
2020
Q1 		$82.8K Hold
9,048
– – ﹤0.01% 2153
2019
Q4 		$126K Hold
9,048
– – ﹤0.01% 2191
2019
Q3 		$156K Hold
9,048
– – ﹤0.01% 2048
2019
Q2 		$246K Hold
9,048
– – ﹤0.01% 1758
2019
Q1 		$173K Hold
9,048
– – ﹤0.01% 1996
2018
Q4 		$85.1K Hold
9,048
– – ﹤0.01% 2364
2018
Q3 		$171K Hold
9,048
– – ﹤0.01% 2111
2018
Q2 		$177K Buy
9,048
+3,157
+54% +$62.4K ﹤0.01% 2029
2018
Q1 		$111K Hold
5,891
– – ﹤0.01% 2242
2017
Q4 		$98K Sell
5,891
-5,192
-47% -$89K ﹤0.01% 2319
2017
Q3 		$228K Buy
+11,083
New +$125K ﹤0.01% 2206

Other funds holding VYGR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s VYGR Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Voyager Therapeutics (VYGR) in Q2 2024, closing a stake of 1,743 shares — an estimated $16.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in VYGR in Q3 2017 and held it in 17 quarters. The position peaked at $246K in Q2 2019. 127 funds tracked by Wall St. Rank hold VYGR as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Voyager Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,743 Voyager Therapeutics shares in Q2 2024, an estimated $16.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Voyager Therapeutics in Q3 2017 and held it in 17 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Voyager Therapeutics position peaked at $246K in Q2 2019.
  • 127 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.